All Stories

  1. Neonatal TSS‐like exanthematous disease
  2. Emetic Potentials of SEl Toxins
  3. Staphylococcal Enterotoxin B Toxic Shock Syndrome Induced by Community-acquired Methicillin-resistant Staphylococcus aureus (CA-MRSA)
  4. Possible role of LECT2 as an intrinsic regulatory factor in SEA-induced toxicity in d-galactosamine-sensitized mice
  5. Staphylococcal enterotoxin B is involved in aggravation and recurrence of murine experimental autoimmune uveoretinitis via Vβ8+CD4+ T cells
  6. Change of specific T cells in an emerging neonatal infectious disease induced by a bacterial superantigen
  7. Interaction between superantigen and T-cell receptor Vβ element determines levels of superantigen-dependent cell-mediated cytotoxicity of CD8+T cells in induction and effector phases
  8. Diagnosis of toxic shock syndrome by two different systems; clinical criteria and monitoring of TSST-1-reactive T cells
  9. Staphylococcal superantigens and the diseases they cause
  10. Cytocidal Effect of Streptococcus pyogenes on Mouse Neutrophils In Vivo and the Critical Role of Streptolysin S
  11. Inhibitory effect of antimicrobial agents and anisodamine on the staphylococcal superantigenic toxin-induced overproduction of proinflammatory cytokines by human peripheral blood mononuclear cells
  12. Maturation of adult peripheral blood CD38+CD4+ T cells demonstrated by cytokine production in response to a superantigen, TSST-1
  13. Early and Definitive Diagnosis of Toxic Shock Syndrome by Detection of Marked Expansion of T-Cell-Receptor Vβ2-Positive T Cells
  14. Immunopathophysiological aspects of an emerging neonatal infectious disease induced by a bacterial superantigen
  15. A New Exanthematous Disease Induced by Toxic Shock Syndrome Toxin-1 in the Early Neonatal Period † 920
  16. Synovial Mononuclear Cells Consist with T Cells Which Produce High Levels of Tumor Necrosis Factor α
  17. Identification of Murine T Cells Reactive with the Bacterial SuperantigenYersinia pseudotuberculosis-Derived Mitogen (YPM) and Factors Involved in YPM-Induced Toxicity in Mice
  18. Tumor necrosis factor production by human T-cells stimulated with bacterial superantigens
  19. Bacterial Superantigens-Mechanism of T Cell Activation by the Superantigens and Their Role in the Pathogenesis of Infectious Diseases
  20. Aloctin A, an active substance ofAloe arborescens Miller as an immunomodulator
  21. Differential effects of cyclosporine and etretinate on serum cytokine levels in patients with psoriasis
  22. Relative Ability of Distinct Isotypes of Human Major Histocompatibility Complex Class II Molecules in Binding Staphylococcal Enterotoxin A
  23. Activation of murine T cells by staphylococcal enterotoxin E: Requirement of MHC class II molecules expressed on accessory cells and identification of Vβ sequence of T cell receptors in T cells reactive to the toxin
  24. Activation of human t cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are hla class ii molecules
  25. Macrophage activation in vivo and inhibition of heat-induced hemolysis by anti-inflammatory substance, Aloctin A.
  26. Aloctin A
  27. Augmentation of lymphokine-activated killer cell activity in vitro by aloctin A
  28. Induction of nonspecific cell-mediated cytotoxic reactivity from non-immune spleen cells treated with aloctin A
  29. Hemopexin levels in mice
  30. Augmentation of natural cell-mediated cytotoxic reactivity of mouse lymphoid cells by Aloctin A
  31. Pharmacological studies on a plant lectin aloctin A II. Inhibitory effect of aloctin A on experimental models of inflammation in rats.
  32. Difference in Genesis between Antigen‐Induced IgM Antibody‐Forming Cells and B‐Cell Mitogen‐Induced IgM Antibody‐Forming Cells in Mouse Spleen Cell Cultures